Literature DB >> 9667561

Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish Multiple Sclerosis Registry.

N Koch-Henriksen1, H Brønnum-Hansen, E Stenager.   

Abstract

OBJECTIVES: To determine the underlying causes of death in a large population based register series of patients with multiple sclerosis.
METHODS: The Danish Multiple Sclerosis Registry, which contains virtually all diagnosed cases of multiple sclerosis in Denmark who were alive in 1949 plus cases with onset of multiple sclerosis in the period 1949-93, who have been diagnosed and notified by 1 January 1994, was linked with the Danish Registry of Causes of Death, in which ICD codes for causes of death from the death certificate are stored for all Danish citizens.
RESULTS: 6068 register cases of multiple sclerosis, who had died in the period 1951-93, were included. Multiple sclerosis was noted on the death certificate as the underlying cause of death in 55.4%; cardiac or vascular diseases in 17.6%; cancers in 8.6%; respiratory or infectious diseases in 5.1%; other natural causes in 9.5%; accident or suicide in 3.8%. The distribution varied with age at death. Standardised mortality ratios (SMRs) were computed on the basis of the 8142 incident cases, who had onset of multiple sclerosis within the period 1951-93; the SMRs for causes of death other than multiple sclerosis were highest for infectious or pulmonary diseases: 2.46 (95% confidence interval (95% CI) 2.04-2.94); suicide: 1.62 (95% CI 1.29-2.01); cardiac or vascular diseases: 1.34 (95% CI 1.22-1.48); accidents 1.34 (95% CI 1.02-1.71); and significantly lower than unity for cancers: 0.79 (95% CI 0.70-0.90), lower for men than for women.
CONCLUSIONS: More than half of the patients with multiple sclerosis die from multiple sclerosis or complications of the disease. Among other causes, patients with multiple sclerosis have an increased risk of dying from heart or vascular diseases but a reduced risk of dying from cancer. An increased risk of death from suicide and accidents can be indirectly attributed to multiple sclerosis. The diminished risk of dying from cancer may be a result of incomplete ascertainment of cancers in disabled patients with multiple sclerosis.

Entities:  

Mesh:

Year:  1998        PMID: 9667561      PMCID: PMC2170172          DOI: 10.1136/jnnp.65.1.56

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Suicide and multiple sclerosis: an epidemiological investigation.

Authors:  E N Stenager; E Stenager; N Koch-Henriksen; H Brønnum-Hansen; K Hyllested; K Jensen; U Bille-Brahe
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

2.  Cause of death in patients attending multiple sclerosis clinics.

Authors:  A D Sadovnick; K Eisen; G C Ebers; D W Paty
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

3.  Underlying cause of death as recorded for multiple sclerosis patients: associated factors.

Authors:  R M Malmgren; N L Valdiviezo; B R Visscher; V A Clark; R Detels; M Fukumoto; J P Dudley
Journal:  J Chronic Dis       Date:  1983

4.  General disease in 120 necropsy-proven cases of multiple sclerosis.

Authors:  I V Allen; J H Millar; M J Hutchinson
Journal:  Neuropathol Appl Neurobiol       Date:  1978 Jul-Aug       Impact factor: 8.090

5.  Multiple sclerosis and cancer in Norway. A retrospective cohort study.

Authors:  R Midgard; E Glattre; M Grønning; T Riise; A Edland; H Nyland
Journal:  Acta Neurol Scand       Date:  1996-06       Impact factor: 3.209

Review 6.  Survival of patients with multiple sclerosis in Denmark: a nationwide, long-term epidemiologic survey.

Authors:  H Brønnum-Hansen; N Koch-Henriksen; K Hyllested
Journal:  Neurology       Date:  1994-10       Impact factor: 9.910

7.  Multiple sclerosis and mortality statistics.

Authors:  J P Larsen; G Kvåle; J A Aarli
Journal:  Acta Neurol Scand       Date:  1985-03       Impact factor: 3.209

8.  Multiple sclerosis and motor neurone disease: survival and how certified after death.

Authors:  F O'Malley; G Dean; M Elian
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

9.  Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.

Authors:  J G Phadke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-05       Impact factor: 10.154

10.  Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway.

Authors:  R Midgard; G Albrektsen; T Riise; G Kvåle; H Nyland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-04       Impact factor: 10.154

View more
  28 in total

Review 1.  Cardiac spectroscopy: techniques, indications and clinical results.

Authors:  Meinrad Beer
Journal:  Eur Radiol       Date:  2004-03-06       Impact factor: 5.315

Review 2.  Clinical prognostic factors in multiple sclerosis: a natural history review.

Authors:  Alexandra Degenhardt; Sreeram V Ramagopalan; Antonio Scalfari; George C Ebers
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

3.  Physical activity and self-reported cardiovascular comorbidities in persons with multiple sclerosis: evidence from a cross-sectional analysis.

Authors:  Robert W Motl; Bo Fernhall; Edward McAuley; Gary Cutter
Journal:  Neuroepidemiology       Date:  2011-05-20       Impact factor: 3.282

4.  Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?

Authors:  Vladimir V Bamm; George Harauz
Journal:  Cell Mol Life Sci       Date:  2014-02-07       Impact factor: 9.261

5.  Exercise and disease progression in multiple sclerosis: can exercise slow down the progression of multiple sclerosis?

Authors:  Ulrik Dalgas; Egon Stenager
Journal:  Ther Adv Neurol Disord       Date:  2012-03       Impact factor: 6.570

Review 6.  Wellness and the Role of Comorbidities in Multiple Sclerosis.

Authors:  Brandon P Moss; Mary R Rensel; Carrie M Hersh
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 7.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

Review 8.  Mortality in patients with multiple sclerosis.

Authors:  Antonio Scalfari; Volker Knappertz; Gary Cutter; Douglas S Goodin; Raymond Ashton; George C Ebers
Journal:  Neurology       Date:  2013-07-09       Impact factor: 9.910

Review 9.  Exercise as Medicine in Multiple Sclerosis-Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives.

Authors:  Ulrik Dalgas; Martin Langeskov-Christensen; Egon Stenager; Morten Riemenschneider; Lars G Hvid
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

10.  Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.

Authors:  Miguel D'haeseleer; Roel Beelen; Yves Fierens; Melissa Cambron; Anne-Marie Vanbinst; Christian Verborgh; Johan Demey; Jacques De Keyser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.